Annual Drug Patent Expirations for CLEVIPREX
Cleviprex is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug.
Drug patent litigation for CLEVIPREX.
This drug has sixty-three patent family members in thirty-three countries.
The generic ingredient in CLEVIPREX is clevidipine. Two suppliers are listed for this compound. Additional details are available on the clevidipine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
